1. Home
  2. Category
  3. Cancer Type

Lung Cancer

Advanced Practice Nursing Issues

Radon Exposure: Using the Spectrum of Prevention Framework to Increase Healthcare Provider Awareness

Jane Worrell
Phillip Gibson
Deborah “Hutch” Allen
CJON 2016, 20(6), 664-666 DOI: 10.1188/16.CJON.664-666
The radioactive properties of radon have been known for decades, but the risks of exposure have been understated in most professional healthcare curriculums. Healthcare providers in areas with low levels of radon exposure may not consider radon to be a main source of concern in the development of...
0
No votes yet
Read this Article
Advanced Practice Nursing Issues

Development and Evaluation of a Lung Cancer Screening Decision Aid

Katelyn Hart
Cindy Tofthagen
Hsiao-Lan Wang
CJON 2016, 20(5), 557-559 DOI: 10.1188/16.CJON.557-559
Lung cancer is the second most common cancer; however, it often is not diagnosed until the advanced stages. Early-stage lung cancer is curable, but screening tools are not usually implemented in practice because of a lack of provider awareness. A lung cancer screening decision aid may increase...
0
No votes yet
Read this Article
Online Exclusive Article

A Sustainable Smoking Cessation Program for Patients With Lung Cancer

Sarah Abrams
CJON 2016, 20(4), E106-E111 DOI: 10.1188/16.CJON.E106-E111
Background: Lung cancer is the most preventable leading cause of cancer death in the United States. Smoking while receiving treatment for lung cancer can decrease the effectiveness of the treatment and may reduce quality of life. Although many smoking cessation proposals have focused on how to...
5
Average: 5 (1 vote)
Read this Article
Online Exclusive Article

The Case for Lung Cancer Screening: What Nurses Need to Know

Kerrin Sorrie
Lisa Cates
Alethea Hill
CJON 2016, 20(3), E82-E87 DOI: 10.1188/16.CJON.E82-E87
Background: Lung cancer screening with low-dose helical computed tomography (LDCT) can improve high-risk individuals’ chances of being diagnosed at an earlier stage and increase survival. Objectives: The aims of this article are to present the risk factors associated with the development of lung...
3
Average: 3 (1 vote)
Read this Article
Article

Programmed Death-1 Inhibition in Cancer With a Focus on Non-Small Cell Lung Cancer: Rationale, Nursing Implications, and Patient Management Strategies

Colleen Lewis
CJON 2016, 20(3), 319-326 DOI: 10.1188/16.CJON.319-326
Background: Programmed death-1 (PD-1) immune checkpoint inhibitors are novel immuno-oncology agents. Unlike chemotherapy or targeted agents, which inhibit tumor cell proliferation or induce tumor cell death, immune checkpoint inhibitors are designed to stimulate a patient’s own immune system to...
0
No votes yet
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.